Full-Time

Executive Director

Confirmed live in the last 24 hours

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops next-generation immuno-oncology therapies

Biotechnology

Compensation Overview

$250,000 - $290,000Annually

Senior, Expert

San Carlos, CA, USA

Required Skills
Communications
Data Analysis
PowerPoint/Keynote/Slides
Requirements
  • BA/BS in Business with an emphasis in economics, finance or mathematics; MBA is preferred.
  • 7 10 years of experience in biopharma investment banking or corporate finance.
  • Demonstrated high level of leadership and managerial skills.
  • Demonstrated extensive background in biopharma corporate finance.
  • Excellent interpersonal and communication skills.
  • Must be able to thrive in a fast-paced, dynamic setting.
  • Must have excellent corporate financial model skills with the ability to build complex and dynamic financial models and to iterate scenario models rapidly.
  • Must have excellent MS PowerPoint skills.
  • Occasional travel (10%) required.
Responsibilities
  • Building relevant models in partnership with colleagues from financial planning and senior leadership, to help inform corporate strategic decisions. Scenario modeling includes (but is not exclusive to): Product NPVs, Corporate development deal modeling, Financial product offerings (IRR or NPV), Long range plan P&L impact, Long range plan cash flow impact
  • Developing executive level financial impact framing, analytics and communication with internal and external audiences, including the Board of Directors, Partners, and Investors
  • Coordinating necessary cross-functional inputs from R&D, Commercial, Legal, Corporate Development, and Finance
  • Evaluating capital requirements for the Company’s growth strategies
  • Partnering cross functionally to evaluate all financial aspects of existing and prospective corporate partnerships
  • Supporting Finance/Financial Planning as needed with LRP and budgeting process to support corporate goals and objectives
  • Tracking critical issues/key milestones as they arise throughout the organization, with an understanding of their potential impact to the financial strategy
  • Tracking current market and industry trends, regulations and policies, and advise on their impact on Corporate Financial Strategy
  • Travel as required, both domestically and internationally, to support financial strategy objectives and activities

With an emphasis on immuno-oncology and cutting-edge therapies, this company stands out in the biotechnology industry for its dedicated approach to cancer treatment and improving patient outcomes. The development and FDA-approval of cutting-edge treatments like toripalimab-tpzi underscore its role as a leader in oncology research. Its focus on next-generation therapies and a differentiated PD-1 inhibitor highlights the company's commitment to both innovation and tangible results in healthcare.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

-6%

2 year growth

-6%

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA